Loading...
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call summary reflects a positive outlook with strong financial performance, including doubled tangible book value and expected loan growth. Management's Q&A responses indicate confidence in asset repricing, deposit stability, and credit outlook, despite increased competition and past dues. The optimistic guidance, particularly in C&I growth and strategic value from treasury capabilities, coupled with a potential buyback, suggests a positive sentiment. However, the lack of specific guidance for 2026 loan growth and vague language regarding strategic initiatives slightly tempers the overall positive sentiment.
Net Income $133 million or $0.22 per diluted share, adjusted net income of $134 million or $0.23 per share. This compares to $106 million and $0.18 on both reported and adjusted basis a quarter ago. The sequential growth in adjusted earnings reflects solid momentum in both net interest income and noninterest income, and a lower loan loss provision.
Core Deposit Growth Approximately 8% year-over-year. This was achieved alongside a 51 basis point reduction in the average cost of deposits for Q2 2025 compared to Q2 2024. Reasons include deliberate investments in talent and technology, targeted market penetration, and the expansion of specialty verticals.
Commercial Loan Growth Nearly 15% year-over-year. This reflects disciplined relationship-driven growth in dynamic commercial markets, particularly in health care and fund finance verticals, which have attractive risk-adjusted return profiles.
Noninterest Income Growth 12% annual rate since 2017, with a focus on capital markets, treasury management, and tax credit advisory offerings. Volatile gain on residential loan sale revenue decreased to 3% of total noninterest income in Q2 2025 from 20% in 2017.
Net Interest Income 3% sequential increase, marking the fifth consecutive quarter of net interest margin (NIM) improvement. This was supported by asset repricing tailwinds and disciplined deposit cost management.
Efficiency Ratio Improved to 55.2%, the best level since Q1 2023. This was driven by strong revenue growth and continued cost discipline.
CRE Concentration Ratio Declined to 349% as of June 30, 2025, from 474% at the end of 2023. This was due to higher origination activity with targeted relationship-driven clients.
Tangible Book Value Growth Grown cumulative tangible book value with dividends over 105% during the CEO's tenure, approximately 15% greater than the peer median.
Noninterest Income Growth: Noninterest income has grown at a 12% annual rate since 2017, driven by capital markets, treasury management, and tax credit advisory offerings.
C&I Loan Growth: C&I portfolio has grown at a 19% compound annual rate since 2017, with nearly 15% growth over the last 12 months, particularly in health care and fund finance verticals.
Geographic Expansion: Strong C&I loan growth in Florida, New Jersey, and Chicago, with fund finance and health care contributing 60% of net growth.
Specialty Verticals: Specialty verticals like international, technology, and private banking now contribute over $12 billion in deposits.
Deposit Growth: Added over 105,000 new deposit accounts in the past 12 months, leading to 8% core deposit growth and a 51 basis point reduction in average cost of deposits.
Efficiency Ratio: Improved to 55.2%, the best level since Q1 2023, driven by strong revenue growth and cost discipline.
Diversification: Focused on diversifying income streams and reducing reliance on volatile revenue sources, with fee income now more stable and client-centric.
CRE Concentration Reduction: CRE concentration ratio declined to 349% from 474% at the end of 2023, surpassing the year-end target ahead of schedule.
Loan Growth: Loan growth is trending toward the lower end of the original guidance, with expectations of approximately 3% growth for the year. This could impact revenue generation and strategic objectives.
Net Charge-Offs: Net charge-offs are expected to range between $100 million to $125 million for the year, indicating potential credit quality challenges.
Provision for Loan Losses: The provision estimate is refined to approximately $150 million for the full year, reflecting potential risks in credit quality and loan performance.
Competitive Pressures on Deposits: Competitive pressures on deposit pricing were noted, though mitigated through disciplined management. This could impact net interest margin if pressures intensify.
CRE Loan Concentration: While CRE concentration has declined, it remains a focus area due to potential risks associated with commercial real estate markets.
Accruing Past Due Loans: Accruing past due loans increased to 40 basis points of total loans, with a significant portion related to CRE loans, highlighting potential credit risks.
Noninterest Expense Growth: Noninterest expenses grew modestly due to salary increases and higher incentive accruals, which could pressure operating efficiency if not managed effectively.
Loan Growth: The company expects approximately 3% loan growth for the full year 2025, consistent with prior updates. However, loan growth is trending toward the lower end of the original guidance.
Net Interest Income Growth: The company has refined its net interest income growth estimate to a range of 8% to 10% for 2025.
Noninterest Income Growth: The outlook for noninterest income remains unchanged at 6% to 10% growth for 2025, supported by capital markets, treasury management, and tax credit advisory offerings.
Noninterest Expense Growth: The company has lowered its noninterest expense growth guidance to a range of 2% to 4%, reflecting ongoing cost discipline and operating leverage.
Net Charge-Offs: Net charge-off expectations have been tightened to a range of $100 million to $125 million for 2025.
Loan Loss Provision: The provision estimate has been refined to approximately $150 million for the full year 2025.
Earnings Per Share: Full-year earnings per share are expected to remain broadly in line with current consensus estimates.
Net Interest Margin (NIM): Further NIM expansion is expected throughout 2025, supported by the interest rate backdrop and additional asset repricing opportunities.
Deposit Growth: Sustained deposit momentum is anticipated, driven by differentiated specialty verticals and alignment of product offerings with client needs.
C&I Loan Growth: While C&I loan growth is expected to moderate, the company remains confident in selectively attracting high-quality relationships.
Credit Normalization: Further credit normalization and a decline in both provision and charge-offs are anticipated throughout the remainder of 2025.
Dividends: As reflected on Slide 7, we have grown cumulative tangible book value with dividends over 105% during my tenure as CEO. This is approximately 15% greater than the peer medium.
The earnings call presents mixed signals. While there are positive aspects like stable financial metrics, a focus on organic growth, and optimistic guidance on deposit growth, there are concerns about competitive pressures, nonaccrual loans, and a moderated loan growth outlook. The Q&A highlights management's confidence in strategic expansions and buybacks but also reveals uncertainties in the CRE market and competitive loan environment. With no new partnerships or major shifts in strategy, the sentiment remains neutral, reflecting the mixed outlook and absence of strong catalysts for significant stock price movement.
The earnings call summary reflects a positive outlook with strong financial performance, including doubled tangible book value and expected loan growth. Management's Q&A responses indicate confidence in asset repricing, deposit stability, and credit outlook, despite increased competition and past dues. The optimistic guidance, particularly in C&I growth and strategic value from treasury capabilities, coupled with a potential buyback, suggests a positive sentiment. However, the lack of specific guidance for 2026 loan growth and vague language regarding strategic initiatives slightly tempers the overall positive sentiment.
The earnings call presents mixed signals: a decrease in net income and EPS, alongside a slight miss in financial expectations, suggests caution. However, positive factors include increased core deposits, improved net interest margin, and a higher allowance coverage ratio. The Q&A highlights stable CRE concentration and core deposit growth, but concerns about spread compression and economic uncertainties persist. With no changes in shareholder return plans and lack of guidance changes, the overall sentiment is neutral, indicating limited stock price movement.
The earnings call presents a mixed picture: while there is stability in core deposits and improved asset quality, net income and EPS have decreased. The Q&A reveals concerns about unclear guidance on CRE balances and loan sales. Despite positive signs like increased tangible book value and adjusted earnings, the overall sentiment is neutral due to the lack of strong growth indicators and management's vagueness on certain future actions.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.